Recombinant activated factor VII for acute subdural haematoma in an elderly patient taking fondaparinux

British Journal of Anaesthesia

Volumn 101, Issue 4, 2008, Pages 575-576

  Bordes, J ^a   Asencio, Y ^a   Kenane, N ^a   Fesselet, J ^a   Meaudre, E ^a   Goutorbe, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FONDAPARINUX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DRUG ANTAGONISM; HEART ATRIUM FIBRILLATION; HUMAN; INTRACRANIAL HYPERTENSION; LETTER; MALE; MYDRIASIS; PRIORITY JOURNAL; STROKE; SUBDURAL HEMATOMA; TRAUMATIC BRAIN INJURY;

ACUTE DISEASE; AGED; ANTICOAGULANTS; COAGULANTS; FACTOR VIIA; HEMATOMA, SUBDURAL, ACUTE; HUMANS; MALE; POLYSACCHARIDES; RECOMBINANT PROTEINS; STROKE;

EID: 51849118438     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen255     Document Type: Letter

References (5)

1. Bijsterveld NR, Moons AH, Boekholdt SM, et al. Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation 2002; 106: 2550-4
2. Lisman T, Bijsterveld NR, Adelmeijer J, et al. Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux. J Thromb Haemost 2003; 1: 2368-73
3. Huvers F, Slappendel R, Benraad B, van Hellemondt G, van Kraaij M. Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid. Neth J Med 2005; 63: 84-6
4. Mayer SA, Brun NC, Broderick J, et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005; 36: 74-9
5. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-85